Inventor
Laurence J. Marton
Inventor
Palo Alto, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Cprimary
C07CAcyclic or carbocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07DHeterocyclic compounds15%
C07KPeptides11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
7,491,849'Oligoamine compounds and derivatives thereof for cancer therapy'20097,453,011'Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor'20087,312,244'Polyamine analog-amino acid conjugates useful as anticancer agents'20077,279,502'Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases'20077,253,207'Quinones as disease therapies'20077,235,695'Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor'20077,198,946'Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis'20077,186,825'Conformationally restricted polyamine analogs as disease therapies'20077,026,347'Porphyrin-polyamine conjugates for cancer therapy'20066,982,351'Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor'20066,809,176'Quinones as disease therapies'20046,794,545'Conformationally restricted polyamine analogs as disease therapies'20046,649,587'Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases'20036,482,943'Quinones as disease therapies'20026,392,098'Conformationally restricted polyamines'20025,977,187'4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growth'19995,889,061'Conformationally restricted polyamines'19995,883,270'4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growth'19995,880,161'Therapeutic polyamines'19995,541,230'Therapeutic polyamines'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–1999Patents assigned to US HEALTH (2)· patent assignee history
1996–2007Based in Fitchburg, WI, US· patent location history
1999–2002Patents assigned to WISCONSIN ALUMNI RES FOUND (4)· patent assignee history
1999–2004Based in Madison, WI, US· patent location history
2002–2004Patents assigned to SLIL BIOMEDICAL CORP (4)· patent assignee history
2006–2007Patents assigned to CELLGATE INC (6)· patent assignee history
2006–2009Based in Palo Alto, CA, US· patent location history
2008–2009Patents assigned to PROGEN PHARMACEUTICALS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELLGATE INC | 6 | 2006–2007 |
| SLIL BIOMEDICAL CORP | 4 | 2002–2004 |
| WISCONSIN ALUMNI RES FOUND | 4 | 1999–2002 |
| PROGEN PHARMACEUTICALS INC | 2 | 2008–2009 |
| US HEALTH | 2 | 1996–1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Palo Alto, California, US | 9 | 2006–2009 |
| Madison, WI, US | 6 | 1999–2004 |
| Fitchburg, WI, US | 5 | 1996–2007 |